Key result
Plasma dopamine-beta-hydroxylase activity did not differ significantly between hypertensive patients and normotensive controls.
Why the study?
Does plasma dopamine-β-hydroxylase activity differ between hypertensive patients and normotensive controls?
Population
S3 hypertensive patients and 93 adult controls. A subsample included 11 patients and controls matched for…
Comparison
Measurement of plasma dopamine-β-hydroxylase… vs Normotensive adult controls
Design
Case-control
Follow-up
12 hours (for subsample)
Authors
Loading...
Plasma DBH lacks diagnostic value in hypertension; leaves open its pathophysiological role.
Case-Control (n=146)
Does plasma dopamine-β-hydroxylase activity differ between hypertensive patients and normotensive controls?
Plasma dopamine-β-hydroxylase activity does not appear to be significantly altered in hypertensive patients compared to controls, nor does it correlate with resting blood pressure.
Åberg et al. (1974) conducted a case-control in Hypertension (n=146). Hypertension vs. Normotensive controls was evaluated on Plasma dopamine-beta-hydroxylase (DBH) activity. Plasma dopamine-beta-hydroxylase activity did not differ significantly between hypertensive patients and normotensive controls.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: